Lucidamide is LifeLink’s brand of “noöpept — a powerful cognitive-enhancing (or “noötropic”) substance. Like many other modern mental-improvement nutraceuticals, noöpept was developed in Russia, where it has been on the market since about 2006.
Noöpept is closely related to a category of mental enhancers called “racetams” and shares their mechanism of action: it increases the sensitivity of certain signal-receptors in nerve cells, and increases the production of nerve growth promoters. But noöpept is effective at far smaller doses than the racetams, and therefore typically has fewer unwanted side effects.
The responses of different people to noöpept (and other noötropics) varies considerably — it depends on genetic factors and perhaps on personal history, as well. There is at present no way to predict which noötropic will be ideal for a given individual. So, to find out whether noöpept is worth using regularly, you simply have to try it and see what it does for you.
For people who respond positively to noöpept, the following benefits are typically reported:
For people who experience unwanted effects from noöpept, the following side effects are the most common ones:
Many users find that these side effects can be avoided by lowering the dosage or by combining noöpept with a “cholinergic” supplement like CDP-choline (“citicoline”).